Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Return on Capital Employed (2019 - 2025)

Dna X (SONM) has disclosed Return on Capital Employed for 7 consecutive years, with 45.47% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Capital Employed rose 4631.0% year-over-year to 45.47%, compared with a TTM value of 45.47% through Sep 2025, up 4631.0%, and an annual FY2024 reading of 8.1%, down 813.0% over the prior year.
  • Return on Capital Employed was 45.47% for Q3 2025 at Dna X, up from 85.86% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 45.47% in Q3 2025 and bottomed at 85.86% in Q2 2025.
  • Average Return on Capital Employed over 5 years is 6.05%, with a median of 1.14% recorded in 2021.
  • Peak annual rise in Return on Capital Employed hit 4631bps in 2025, while the deepest fall reached -8530bps in 2025.
  • Year by year, Return on Capital Employed stood at 2.04% in 2021, then skyrocketed by 61bps to 0.8% in 2022, then skyrocketed by 103bps to 0.02% in 2023, then tumbled by -234965bps to 47.85% in 2024, then soared by 195bps to 45.47% in 2025.
  • Business Quant data shows Return on Capital Employed for SONM at 45.47% in Q3 2025, 85.86% in Q2 2025, and 9.56% in Q1 2025.